PRNP and infection: Our findings reveal that the M-NO3 moose isolate was able to induce clinical disease in gene-targeted mice expressing the 138NN-PrPC variant, an experimental host that previously only showed subclinical infection, i.e., prions were detected by in vitro amplification, but infected mice did not display clinical signs, upon infection with North American CWD isolates [29].